Daisuke Imai, Zachary P. Rokop, Masaya Yokoyama, Amit Sharma, Plamen Mihaylov, John Powelson, Seung Duk Lee, Muhammad I. Saeed, Dhiren Kumar, Asif Sharfuddin, Rachel Holmes, Marco Lacerda, Joel Wedd, Jill M. Bruno, Jordan K. Swensson, David A. Bruno, Chandrashekhar A. Kubal, Vinay Kumaran
{"title":"序贯活体肾-肝供者接受右叶捐献的肾功能:一项双中心病例研究","authors":"Daisuke Imai, Zachary P. Rokop, Masaya Yokoyama, Amit Sharma, Plamen Mihaylov, John Powelson, Seung Duk Lee, Muhammad I. Saeed, Dhiren Kumar, Asif Sharfuddin, Rachel Holmes, Marco Lacerda, Joel Wedd, Jill M. Bruno, Jordan K. Swensson, David A. Bruno, Chandrashekhar A. Kubal, Vinay Kumaran","doi":"10.1111/ctr.70168","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>There are concerns regarding the potential impact of living donor hepatectomy on the kidney function of prior kidney donors. The current literature lacks comprehensive data on living liver following living kidney donation. Furthermore, the focus on left lobe donation in the literature does not fully represent the prevalent use of the right lobe graft for living liver transplants in the United States.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We performed a retrospective chart review on all living liver donors who had previously donated a kidney at two US centers.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>There were 14 sequential living kidney-then-liver donors. The median donor age was 49 years (range 35–59). Most of these (12 donors) were nondirected donations. The median follow-up period was 24 months (range 1–129). The median interval between the donations was 32 months (range 17–154 months). All donors donated the right lobe with 43.5% (range 31.4%–49.9 %) of remnant liver volume. The overall donor complication rate was 43%, seen in six donors, with one Clavien–Dindo Grade IIIa complication (suture granuloma removal under local anesthesia). Two donors (14%) experienced stage 1 AKI, both resolving with supportive care. A decrease in eGFR greater than 10 mL/min/1.73 m<sup>2</sup> over the follow-up was observed in only one donor, who gained weight and was lost to follow-up. Compensatory kidney hypertrophy was observed, with kidney volumetry showing an increase of 1.27 (1.09–1.39) times pre- versus post-kidney donation and 1.08 times pre- versus post-liver donation (1.01–1.16).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Right lobe living liver donation in previous kidney donors might be safely performed in terms of midterm kidney function. Longer-term assessment in a larger cohort would be necessary to have better insight into this unique donor group.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 5","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Renal Function in Sequential Living Kidney-Then-Liver Donors Undergoing Right Lobe Donation: A Two-Center Case Study\",\"authors\":\"Daisuke Imai, Zachary P. Rokop, Masaya Yokoyama, Amit Sharma, Plamen Mihaylov, John Powelson, Seung Duk Lee, Muhammad I. Saeed, Dhiren Kumar, Asif Sharfuddin, Rachel Holmes, Marco Lacerda, Joel Wedd, Jill M. Bruno, Jordan K. Swensson, David A. Bruno, Chandrashekhar A. Kubal, Vinay Kumaran\",\"doi\":\"10.1111/ctr.70168\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>There are concerns regarding the potential impact of living donor hepatectomy on the kidney function of prior kidney donors. The current literature lacks comprehensive data on living liver following living kidney donation. Furthermore, the focus on left lobe donation in the literature does not fully represent the prevalent use of the right lobe graft for living liver transplants in the United States.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We performed a retrospective chart review on all living liver donors who had previously donated a kidney at two US centers.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>There were 14 sequential living kidney-then-liver donors. The median donor age was 49 years (range 35–59). Most of these (12 donors) were nondirected donations. The median follow-up period was 24 months (range 1–129). The median interval between the donations was 32 months (range 17–154 months). All donors donated the right lobe with 43.5% (range 31.4%–49.9 %) of remnant liver volume. The overall donor complication rate was 43%, seen in six donors, with one Clavien–Dindo Grade IIIa complication (suture granuloma removal under local anesthesia). Two donors (14%) experienced stage 1 AKI, both resolving with supportive care. A decrease in eGFR greater than 10 mL/min/1.73 m<sup>2</sup> over the follow-up was observed in only one donor, who gained weight and was lost to follow-up. Compensatory kidney hypertrophy was observed, with kidney volumetry showing an increase of 1.27 (1.09–1.39) times pre- versus post-kidney donation and 1.08 times pre- versus post-liver donation (1.01–1.16).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Right lobe living liver donation in previous kidney donors might be safely performed in terms of midterm kidney function. Longer-term assessment in a larger cohort would be necessary to have better insight into this unique donor group.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10467,\"journal\":{\"name\":\"Clinical Transplantation\",\"volume\":\"39 5\",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70168\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70168","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Renal Function in Sequential Living Kidney-Then-Liver Donors Undergoing Right Lobe Donation: A Two-Center Case Study
Background
There are concerns regarding the potential impact of living donor hepatectomy on the kidney function of prior kidney donors. The current literature lacks comprehensive data on living liver following living kidney donation. Furthermore, the focus on left lobe donation in the literature does not fully represent the prevalent use of the right lobe graft for living liver transplants in the United States.
Methods
We performed a retrospective chart review on all living liver donors who had previously donated a kidney at two US centers.
Results
There were 14 sequential living kidney-then-liver donors. The median donor age was 49 years (range 35–59). Most of these (12 donors) were nondirected donations. The median follow-up period was 24 months (range 1–129). The median interval between the donations was 32 months (range 17–154 months). All donors donated the right lobe with 43.5% (range 31.4%–49.9 %) of remnant liver volume. The overall donor complication rate was 43%, seen in six donors, with one Clavien–Dindo Grade IIIa complication (suture granuloma removal under local anesthesia). Two donors (14%) experienced stage 1 AKI, both resolving with supportive care. A decrease in eGFR greater than 10 mL/min/1.73 m2 over the follow-up was observed in only one donor, who gained weight and was lost to follow-up. Compensatory kidney hypertrophy was observed, with kidney volumetry showing an increase of 1.27 (1.09–1.39) times pre- versus post-kidney donation and 1.08 times pre- versus post-liver donation (1.01–1.16).
Conclusions
Right lobe living liver donation in previous kidney donors might be safely performed in terms of midterm kidney function. Longer-term assessment in a larger cohort would be necessary to have better insight into this unique donor group.
期刊介绍:
Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored.
Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include:
Immunology and immunosuppression;
Patient preparation;
Social, ethical, and psychological issues;
Complications, short- and long-term results;
Artificial organs;
Donation and preservation of organ and tissue;
Translational studies;
Advances in tissue typing;
Updates on transplant pathology;.
Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries.
Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.